Skip to Content

Notice

Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

The meeting announced below concerns Evaluating Innovative and Promising Strategies to prevent Suicide among Middle-Aged Men, Funding Opportunity Announcement (FOA), RFA-CE-15-004, initial review.

In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting:

Time and Date:

12:00 p.m.-5:00 p.m., EDT, June 30, 2015 (CLOSED)

Place: Teleconference

Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92-463.

Matters for Discussion: The meeting will include the initial review, discussion, and evaluation of applications received in response to “Evaluating Innovative and Promising Strategies to prevent Suicide among Middle-Aged Men, RFA-CE-15-004. This meeting is being reconvened to review two applications that were not reviewed during the initial meeting on June 2, 2015.

Contact Person for More Information: Gwendolyn Cattledge, Ph.D., M.S.E.H., Scientific Review Officer, CDC, 4770 Buford Hwy. NE., Mailstop E63, Atlanta, Georgia 30341-3724, Telephone: 770-488-4655.

The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.

Start Signature

Elaine L. Baker,

Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.

End Signature End Preamble

[FR Doc. 2015-14087 Filed 6-9-15; 8:45 am]

BILLING CODE 4163-18-P